Streetbeat News

Products Services

NVO

Ross Gerber, a notable Tesla investor, highlighted on X (formerly Twitter) the potential cost-saving benefits of using Ozempic, a weight-loss drug by Novo Nordisk A/S (NYSE:NVO). He suggested that the drug could reduce monthly food expenses significantly, citing a user's experience of saving nearly $1,000 a month. The discussion also touched on the broader implications for the food and beverage industry and the public's skepticism towards new weight loss drugs despite high-profile endorsements.

Portfolio Pulse from Benzinga Neuro

March 20, 2024 | 8:20 am

FRSH

Porsche eBike Performance, launched in 2022 to innovate in the e-bike sector, has partnered with Freshworks to enhance IT efficiency through AI-powered enterprise software. This collaboration aims to standardize processes and improve support for Porsche eBike's rapidly expanding team of over 300 employees.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:06 am

LTRX

Lantronix has introduced the M114 CAT-1BIS modem, expanding its M110 Mobility Solutions. This new modem, available in EMEA markets, features Lantronix's Percepxion IoT software for secure device lifecycle management at the edge.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:04 am

CTSH

Cermaq has extended its collaboration with Cognizant to enhance operational efficiencies. Cognizant will provide managed infrastructure services and help modernize Cermaq's cloud landscape as a digital transformation partner in Norway and Canada.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 8:03 am

RIVN

Rivian Automotive (NASDAQ:RIVN) announced that existing Rivian customers will receive priority delivery for its second-generation EV, the R2, expected in 2026. The R2 SUV, unveiled earlier this month, is priced around $45,000, aiming to compete with Tesla's Model Y. Rivian's R1 models, catering to the higher end of the EV market, start at $69,900 and $74,900. The company has received over 68,000 reservations for the R2 in less than a day, indicating strong demand.

Portfolio Pulse from Anan Ashraf

March 20, 2024 | 7:34 am

BLK

BlackRock Inc (NYSE:BLK) has filed with the SEC to create a new fund focused on tokenized assets, named the BlackRock USD Institutional Digital Liquidity Fund, in partnership with Securitize. The fund, based in the British Virgin Islands and founded in 2023, aims to attract capital with a minimum investment threshold of $100,000, allowing investments up to $100 million. This development aligns with the market's optimism for Ethereum-based ETFs, following the SEC's approval of Bitcoin ETFs. BlackRock's move into tokenization reflects a broader industry trend towards digital financial assets.

Portfolio Pulse from Mehab Qureshi

March 20, 2024 | 7:13 am

STLA

Stellantis Ventures has invested in SteerLight, a developer of innovative, cost-effective LiDAR technology for advanced driver assistance systems (ADAS). SteerLight's on-chip LiDAR offers exceptional sensing precision and resolution, making it a compact and affordable solution that aligns with Stellantis' Dare Forward 2030 strategic plan for clean, safe, and affordable mobility.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 7:07 am

NVDA

SNPS

Synopsys Inc's CEO, Sassine Ghazi, highlighted the company's pivotal role in the chip design industry, especially for NVIDIA Corporation, in an interview with Jim Cramer. Ghazi emphasized Synopsys' importance in Nvidia's graphics chip development for AI technology, using their electronic design automation software for chip architecture, design, and verification. Additionally, Synopsys' recent acquisition of Ansys for $35 billion is expected to enhance their capability to predict graphics chips' real-world performance. Despite Nvidia's stock dropping slightly post-GTC2024 event, Synopsys saw a significant rise, underscoring its industry importance.

Portfolio Pulse from Benzinga Neuro

March 20, 2024 | 6:49 am

BB

BlackBerry has partnered with Rogers Cybersecure Catalyst to enhance cybersecurity skills in Malaysia through a new leadership program under the BlackBerry Cybersecurity Center of Excellence in Kuala Lumpur. The program will offer full-tuition scholarships specifically for women.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 6:33 am

VALN

Valneva has updated its 2024 financial guidance, raising product sales forecasts to €160M-€180M from the previous €150M-€180M. Total revenues are now expected to be €170M-€190M, up from €153.7M in 2023. This adjustment is due to an improved outlook on IXIARO supply constraints and strong sales of travel vaccines and IXCHIQ. The company also anticipates lower R&D expenses and significant non-dilutive contributions for R&D. Other income is expected to be €100M-€110M, including proceeds from a PRV sale. Valneva projects a lower cash burn in 2024 and expects its commercial business to be cash-flow positive from 2025.

Portfolio Pulse from Benzinga Newsdesk

March 20, 2024 | 6:32 am